QuiaPEG Pharmaceuticals Holding AB (QUIA) — Strategic Asset Allocation Index

Latest as of June 2023: 4.6%

QuiaPEG Pharmaceuticals Holding AB (QUIA) has a Strategic Asset Allocation Index of 4.6% as of June 2023. Strategic assets (PP&E of Skr397.00K plus long-term investments of Skr-) total Skr397.00K, measured against net assets of Skr8.71 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

4.6%
Strategic Assets / Net Assets

Strategic Assets

Skr397.00K
PP&E + LT Investments

PP&E

Skr397.00K
SEK

Net Assets

Skr8.71 Million
SEK

QuiaPEG Pharmaceuticals Holding AB Strategic Asset Allocation Index (2018–2022)

This chart shows how QuiaPEG Pharmaceuticals Holding AB's Strategic Asset Allocation Index has evolved across 4 annual periods from 2018 to 2022. As of June 2023, the index stands at 4.6%, representing strategic assets of Skr397.00K against net assets of Skr8.71 Million SEK. Explore cash flow conversion of QuiaPEG Pharmaceuticals Holding AB to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for QuiaPEG Pharmaceuticals Holding AB (2018–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for QuiaPEG Pharmaceuticals Holding AB from 2018 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of QuiaPEG Pharmaceuticals Holding AB.

Year SAAI Strategic Assets (SEK) PP&E LT Investments Net Assets Change (pp)
2022 21.7% Skr524.00K Skr524.00K Skr- Skr2.41 Million ▼ -3514.6 pp
2021 3536.4% Skr778.00K Skr778.00K Skr- Skr22.00K ▲ +2216.6 pp
2020 1319.7% Skr937.00K Skr937.00K Skr- Skr71.00K ▲ +1292.6 pp
2018 27.2% Skr148.00K Skr148.00K Skr- Skr545.00K
pp = percentage points